Abstract

Background Primary coronary angioplasty is an effective reperfusion strategy in acute myocardial infarction. However, its availability is limited, and transporting patients to an angioplasty centre in the acute phase of myocardial infarction has not yet been proved safe.

Methods The PRAGUE study (PRimary Angioplasty in patients transferred from General community hospitals to specialized PTCA Units with or without Emergency thrombolysis) compared three reperfusion strategies in patients with acute myocardial infarction, presenting within 6h of symptom onset at community hospitals without a catheterization laboratory: group A—thrombolytic therapy in community hospitals (n=99), group B—thrombolytic therapy during transportation to angioplasty (n=100), group C—immediate transportation for primary angioplasty without pre-treatment with thrombolysis (n=101).

Results No complications occurred during transportation in group C. Two ventricular fibrillations occurred during transportation in group B. Median admission–reperfusion time in transported patients (group B 106min, group C 96min) compared favourably with the anticipated >90min in group A. The combined primary end-point (death/reinfarction/stroke at 30 days) was less frequent in group C (8%) compared to groups B (15%) and A (23%, P<0·02). The incidence of reinfarction was markedly reduced by transport to primary angioplasty (1% in group C vs 7% in group B vs 10% in group A,P <0·03).

Conclusions Transferring patients from community hospitals to a tertiary angioplasty centre in the acute phase of myocardial infarction is feasible and safe. This strategy is associated with a significant reduction in the incidence of reinfarction and the combined clinical end-point of death/reinfarction/stroke at 30 days when compared to standard thrombolytic therapy at the community hospital.

f1
Correspondence: Petr Widimský, MD, PhD, FESC, Cardiocenter Vinohrady, Šrobárova 50, 100 34 Prague 10, Czech Republic.

References

1
Lancet
 .
1986
;
1
:
397
–402
2
Barbagelata
NA
, Granger CB, Oqueli E. TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: a pooled analysis.
Am Heart J
 .
1997
;
133
:
273
–282
3
Gulba
DC
, Tanswell P, Dechend R. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
J Am Coll Cardiol
 .
1997
;
30
:
1611
–1617
4
Meyer
J
, Merx W, Dorr R, Lambertz H, Bethge C, Effert S. Succesful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recanalization and percutaneous transluminal coronary angioplasty.
Am Heart J
 .
1982
;
103
:
132
–138
5
Hartzler
GO
, Rutherford BD, McConnay DR. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction.
Am Heart J
 .
1983
;
106
:
965
–973
6
Zijlstra
F
, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.
N Engl J Med
 .
1993
;
328
:
680
–684
7
Grines
CL
, Browne KF, Marco J. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction.
N Engl J Med
 .
1993
;
328
:
673
–679
8
Gibbons
RJ
, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction.
N Engl J Med
 .
1993
;
328
:
685
–691
9
N Engl J Med
 .
1997
;
336
:
1621
–1628
10
Stone
GW
, Grines CL, O'Neill WW. Primary coronary angioplasty versus thrombolysis.
N Engl J Med
 .
1997
;
337
:
1168
–1169
11
Christian
TF
, O'Keefe JH, DeWood MA. Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction.
Am Heart J
 .
1998
;
135
:
310
–317
12
Zijlstra
F
, Beukema WP, van't Hof AWJ. A randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with an acute myocardial infarction.
J Am Coll Cardiol
 .
1997
;
29
:
908
–912
13
Brown
DL
. An analysis of percutaneous transluminal coronary angioplasty performed in California in 1995.
J Am Coll Cardiol
 .
1998
;
32
:
14
Weaver DW, Cerqueira M, Hallstrom AP. Pre-hospital-initiated vs. hospital-initiated thrombolytic therapy. The myocardial infarction triage and intervention trial.
JAMA
 .
1993
;
270
:
1211
–1216
15
Rawles
JM
. Quantification of the benefit from earlier thrombolytic therapy: the Grampion Regional Anistreplase Trial (GREAT).
J Am Coll Cardiol
 .
1997
;
30
:
1181
–1186
16
van't Hof
AWJ
, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F. Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction.
Eur Heart J
 .
1998
;
19
:
118
–123
17
Liem
AL
, van't Hof AWJ, Hoorntje JCA, de Boer MJ, Suryapranata H, Zijlstra F. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty.
J Am Coll Cardiol
 .
1998
;
32
:
629
–633
18
Zijlstra
F
, van't Hof AWJ, Liem AL, Hoorntje JCA, Suryapranata H, de Boer MJ. Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction.
Heart
 .
1997
;
78
:
333
–336
19
Barron
HV
, Malacreda R, Weaver WD. Use of helicopter transportation in acute myocardial infarction in the United States.
J Am Coll Cardiol
 .
1998
;
32
:
20
Vermeer
F
, Werter C, van de Berg E. Safety and feasibility of rescue PTCA or primary PTCA in patients with acute myocardial infarction admitted to a hospital without PTCA facilities.
J Am Coll Cardiol
 .
1997
;
29
:
390A
21
Buděšı́nský
T
, Widimský P, Dvořák J, Lisa L. Transport of patients with acute myocardial infarction to coronary angioplasty.
Cor Vasa
 .
1998
;
40
:
368
–369
22
Willerson
JT
, Watson JT, Hutton I, Templeton GH, Fixler DE. Reduced myocardial reflow and increased coronary vascular resistence following prolonged myocardial ischemia in the dog.
Circ Res
 .
1975
;
36
:
771
–781
23
Reimer
KA
, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration of coronary occlusion in dogs.
Circulation
 .
1977
;
56
:
786
–794
24
Hasche
ET
, Fernandes C, Freedman SB, Jeremy RW. Relation between ischemia time, infarct size, and left ventricular function in humans.
Circulation
 .
1995
;
92
:
710
–719
25
Raitt
MH
, Maynard C, Wagner GS, Cerqueirra MD, Selvester RH, Weaver WD. Relation between symptom duration before thrombolytic therapy and final myocardial infarct size.
Circulation
 .
1996
;
93
:
48
–53
26
Brodie
BR
, Stuckey TD, Wall TC. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction.
J Am Coll Cardiol
 .
1998
;
32
:
1312
–1319
27
Stone
GW
, O'Keefe J, Brodie BR, O'Neill WW, Grines CL. Lack of relationship between the time to reperfusion and short term mortality after primary infarct angioplasty.
J Am Coll Cardiol
 .
1998
;
32
:
28
French
WJ
, Sada MJ. Benefit of primary angioplasty in patients presenting late with ST segment elevation and acute myocardial infarction.
J Am Coll Cardiol
 .
1998
;
32
:
29
J Am Coll Cardiol
 .
1996
;
28
:
1328
–1428
30
Lee
KL
, Woodlief LH, Topol EJ. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41021 patients.
Circulation
 .
1995
;
91
:
1659
–1668
31
Erbel
R
, Pop T, Henrichs KJ, Rupprecht HJ, Steuernagel C, Meyer J. Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial.
J Am Coll Cardiol
 .
1986
;
8
:
485
–495
32
Simoons
ML
, Arnold AER, Betriu A. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.
Lancet
 .
1988
;
I
:
197
–203
33
N Engl J Med
 .
1989
;
320
:
618
–627
34
Br Med J
 .
1991
;
302
:
555

Comments

0 Comments